share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Feb 9 01:31

Gainers

  • Syra Health (NASDAQ:SYRA) shares rose 479.7% to $6.44 during Thursday's regular session. The company's market cap stands at $41.3 million.
  • NanoString Technologies (NASDAQ:NSTG) stock moved upwards by 197.18% to $0.16. The market value of their outstanding shares is at $7.6 million.
  • Foghorn Therapeutics (NASDAQ:FHTX) shares increased by 34.35% to $4.19. The market value of their outstanding shares is at $176.9 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock increased by 27.87% to $3.67. The company's market cap stands at $15.8 million.
  • Akanda (NASDAQ:AKAN) shares increased by 24.03% to $0.38. The company's market cap stands at $2.2 million.
  • Femasys (NASDAQ:FEMY) stock rose 23.93% to $1.45. The market value of their outstanding shares is at $31.3 million.

Losers

  • Tenax Therapeutics (NASDAQ:TENX) stock fell 64.7% to $5.04 during Thursday's regular session. The market value of their outstanding shares is at $1.7 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares decreased by 31.2% to $0.25. The market value of their outstanding shares is at $3.0 million.
  • Dynatronics (NASDAQ:DYNT) stock declined by 24.67% to $0.51. The market value of their outstanding shares is at $2.3 million. As per the news, the Q2 earnings report came out yesterday.
  • Cadrenal Therapeutics (NASDAQ:CVKD) shares fell 22.13% to $0.88. The market value of their outstanding shares is at $11.4 million.
  • Minerva Neurosciences (NASDAQ:NERV) shares decreased by 21.49% to $8.45. The market value of their outstanding shares is at $59.0 million.
  • 23andMe Holding (NASDAQ:ME) shares decreased by 21.06% to $0.57. The market value of their outstanding shares is at $274.1 million. The company's, Q3 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment